Josh A. McCreary - 23 Feb 2026 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Role
Senior VP & General Counsel
Signature
/s/ Josh McCreary
Issuer symbol
NHC
Transactions as of
23 Feb 2026
Net transactions value
$0
Form type
4
Filing time
25 Feb 2026, 17:24:37 UTC
Previous filing
05 Jan 2026
Next filing
03 Mar 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
McCreary Josh A Senior VP & General Counsel 100 VINE STREET, MURFREESBORO /s/ Josh McCreary 25 Feb 2026 0001774116

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding NHC Common Stock 9,942 23 Feb 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NHC Option to Purchase Common Stock Award $0 +14,000 $0.000000 14,000 23 Feb 2026 Common Stock 14,000 $157.13 Direct F1, F2
holding NHC Option to Purchase Common Stock 4,000 23 Feb 2026 Common Stock 4,000 $53.94 Direct
holding NHC Option to Purchase Common Stock 8,000 23 Feb 2026 Common Stock 8,000 $94.10 Direct
holding NHC Option to Purchase Common Stock 13,500 23 Feb 2026 Common Stock 13,500 $90.62 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on February 23, 2026. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
F2 These stock options will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on February 23, 2027; one-third (1/3) will vest on February 23, 2028; and the final one-third (1/3) will vest on February 23, 2029.